What establishes the diagnosis?
Malaria
Diagnostic overview
Malaria diagnostic testing only; travel/exposure and clinical context remain necessary.
CDC: Public diagnostic overview
Scope of this clinical reference
- Repeat-testing rules, species-specific distinctions, severity and other deployment-associated infections remain open.
How is it connected to service?
The applicable direct, secondary, aggravation or presumptive route determines the service-connection evidence. Use the evidence guide to distinguish these routes.
Explore service-connection evidence →What do the rating levels describe?
A diagnosis does not automatically establish a percentage. These are the source requirements for evaluating severity; related notes and exceptions still apply.
Compare these levels with the original rating table
Find DC 6304 in the rating schedule
The highlighted row marks this code. Nearby rows provide context and can describe other conditions. Use the full schedule for applicable headings, footnotes and exceptions.
| Rating | |
|---|---|
| As active disease | 100 |
| Note: Continue a 100 percent evaluation beyond the cessation of treatment for active disease. Six months after discontinuance of such treatment, determine the appropriate disability rating by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. Thereafter, rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, skin lesions, peripheral neuropathy, or amputations. | |
| 6304 Malaria: | |
| Evaluate under the General Rating Formula. | |
| Note 1: The diagnosis of malaria, both initially and during relapse, depends on the identification of the malarial parasites in blood smears or other specific diagnostic laboratory tests such as antigen detection, immunologic (immunochromatographic) tests, and molecular testing such as polymerase chain reaction tests. | |
| Note 2: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, liver or splenic damage, and central nervous system conditions. | |
| 6305 Lymphatic filariasis, to include elephantiasis: | |
| Evaluate under the General Rating Formula. | |
| Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, epididymitis, lymphangitis, lymphatic obstruction, or lymphedema affecting extremities, genitals, and/or breasts. |
Related notes and evaluation rules
Note 1: The diagnosis of malaria, both initially and during relapse, depends on the identification of the malarial parasites in blood smears or other specific diagnostic laboratory tests such as antigen detection, immunologic (immunochromatographic) tests, and molecular testing such as polymerase chain reaction tests.
Note 2: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, liver or splenic damage, and central nervous system conditions.
Evaluate under the General Rating Formula. |
Note 2: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, liver or splenic damage, and central nervous system conditions. |
After active disease has resolved, rate at 0 percent for infection. Rate any residual disability of infection within the appropriate body system. |
What can professional assessments clarify?
A test score alone does not establish a VA percentage or service connection.
Which evidence addresses the questions?
- Diagnosis and history: Records identifying the current diagnosis, onset, course, and relevant medical history.
- Diagnostic tests and measurements: Condition-relevant tests, imaging, laboratory results, and objective measurements.
- Symptoms and episodes: Records or statements documenting symptoms, severity, frequency, duration, and episodes.
- Clinical findings: Examination findings that are relevant to the public DBQ or rating criteria.
- Scars and residual findings: Records describing relevant scars and residual physical findings.
- Functional impact: Medical and lay evidence describing work and daily-activity effects.
- Service connection evidence: Evidence addressing an in-service event, exposure, disease, injury, continuity, or a secondary relationship.
Find evidence in the Infectious Diseases (other than HIV-related illness chronic fatigue syndrome and tuberculosis) questionnaire
Use these section names and page numbers to locate the examiner’s findings. Some sections apply only to particular diagnoses within this family.
- diagnosis · p. 1, 2
- medical history · p. 3
- status, symptoms, and residuals · p. 3, 4
- other pertinent physical findings, scars, complications, conditions, signs and/or symptoms · p. 4
- diagnostic testing · p. 5, 6
- functional impact · p. 6
- remarks · p. 7
Find evidence in the Persian Gulf/Afghanistan Infectious Diseases questionnaire
Use these section names and page numbers to locate the examiner’s findings. Some sections apply only to particular diagnoses within this family.
- diagnosis · p. 1, 2
- medical history for disease #1 · p. 2
- medical history for disease #2 · p. 3
- medical history for disease #3 · p. 3, 4
- additional persian gulf and/or afghanistan infectious diseases · p. 4
- other pertinent physical findings, complications, conditions, signs, symptoms, and scars · p. 4, 5
- diagnostic testing · p. 5, 6
- functional impact · p. 6
- remarks · p. 6
Shared library and examination references
How an independent medical review works →Sources and scope
Clinical and evidence sources
Guide source check: 2026-11-06. Rating-library snapshot: June 30, 2026. Source coverage is distinct from clinical review. This page does not diagnose, adjudicate a claim, or collect medical records.
Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.